|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Patelet GPIIb/IIIa (PIAI/2)Pol- ymorphism in SLE : clinical and laboratory association 显示文摘 | Tolusso B Fabrism Gremese E | 2003 | Ann Rheum Kis2003，40，8： | 1 |
| 2 | Autoantibodies and thrombophilia in RA: TNF and TNF blockers显示文摘 | Ferraccioli GF Gremese E | 2004 | Annals of the Rheumatic Diseases2004，63，： | 1 |
| 3 | The metabolic syndrome: the cross- roads between rheumatoid arthritis and cardiovascular risk 显示文摘 | Gremese E Ferraccioli G | 2011 | Autoimmun Rev2011，10，： | 1 |
| 4 | Pathogenetic, clinical and pharmaco-economic assessment in rheuma- toid arthritis (RA)显示文摘 | Ferraccioli G Gremese E | 2011 | Intern Emerg Med2011，6，1： | 1 |
| 5 | Thrombagenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers显示文摘 | Ferraceioli G Gremese E | 2004 | Autoimmun Rev2004，3，4： | 1 |
| 6 | Platelet GPIlb/IIIa (PIA 1/2) polymorphism in SLE:clinical and laboratory association显示文摘 | i Tolusso B Fabris M Gremese E | 2003 | Ann Rheum Dis2003，62，8： | 1 |
| 7 | Platelet GPIIb/IIIa ( P1 A 1/ 2) polymorphism in SLE: clinical and laboratory association 显示文摘 | Tolusso B Fabris M Gremese E | 2003 | Ann Rheum Dis2003，62，8： | 1 |
| 8 | Platelet GPIIb/IIIa(PIA1/2) Polymorphism in SEE:clinical and labora tory association显示文摘 | Tolusso B fabrism Gremese E | 2003 | Ann Rheum Kis2003，40，8： | 1 |
| 9 | Platelet GPⅡb/Ⅲa (PIA 1/2) polymorphism in SLE: clinical and laboratory association 显示文摘 | Tolusso B Fabris M Gremese E | 2003 | Ann Rheum Dis2003，62，8： | 1 |
| 10 | Platelet GP Ⅱb/Ⅲa (PIA 1/2) polymorphism in SLE: clinical and laboratory association显示文摘 | Tolusso B Fabris M Gremese E | 2003 | Ann Rheum Dis2003，62，78： | 1 |
| 11 | Analysis of improvements, full responses, remissionand toxicity in rheumatoid patients treated with step-up combination therapy (mathotraxate, cyclosporine A, sulphasalazine) or monotherapy for three years 显示文摘 | Ferraccoill GF Gremese E Tomletto P | 2002 | Rheumatology (Oxford)2002，41，8： | 1 |
| 12 | Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes:TNF alpha blockers显示文摘 | FERRACCIOLI G GREMESE E | 2004 | Autoimmun Rev2004，3，4： | 1 |
| 13 | Memory B cell suhsets and plasmablasts are lower in early than in long-standing rheuma- toid arthritis显示文摘 | Fedele AL Tolusso B Gremese E | 2014 | BMC Immunol2014，15，： | 1 |
| 14 | Platelet GPⅡb/Ⅲa(PIA 1/2)polymorphism in SLE: clinical and laboratory association 显示文摘 | Tolusso B Fabris M Gremese E | 2003 | Ann Rheum Dis2003，62，8： | 1 |
| 15 | Pathogenetic, clinical and pharmaco-economic assessment in rheuma- toid arthritis (RA)显示文摘 | Ferraccioli G Gremese E | 2011 | Intern Emerg Med2011，6，1： | 1 |
| 16 | Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis:an approach to a personalized medicine显示文摘 | Gremese E Carletto A Padovan M | | 0，，01： | 1 |
| 17 | Ptatelet GPⅡb/ Ⅲa(PIA1/2) Polymorphism in SLE: clinical and laboratory association显示文摘 | Tolusso B Fabrism Gremese E | 2003 | Ann Rheum Dis2003，62，8： | 1 |
| 18 | Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years显示文摘 | Ferraccioli GF Gremese E Tomoetto P | 2002 | Rheumatology (Oxford)2002，41，8： | 1 |
| 19 | Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA)显示文摘 | Ferraccioli G Gremese E | 2011 | Intern Emerg Med2011，6，1： | 1 |
| 20 | Benefit/risk of cyclosporine in rheumatoid arthritis显示文摘 | Gremese E Ferraccioli GF | 2004 | Clin Exp Rheumatol2004，22，5135： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员